Adrian Krainer wins 2019 Peter Speiser Award 11/27/2019 Professor Adrian Krainer was awarded the Peter Speiser Award for advances in the pharmaceutical sciences. Read the story »
Adrian Krainer elected to National Academy of Medicine 10/23/2019 Professor Adrian Krainer joins the National Academy of Medicine in honor of his groundbreaking work on SMA. Read the story »
Adrian Krainer wins Zülch Prize for lifesaving SMA Treatment 10/8/2019 Professor Adrian Krainer is awarded the K-J. Zülch Prize for the development and testing of a first-of-its-kind treatment for spinal muscular atrophy. Read the story »
Adrian Krainer wins RNA Society’s Lifetime Achievement Award 3/8/2019 Professor Adrian Krainer was awarded the RNA Society’s Lifetime Achievement Award for his life-saving research. Read the story »
National Academy of Inventors Fellow, Adrian Krainer 12/11/2018 Professor Adrian Krainer has been named a NAI 2018 Fellow for his work on the first FDA-approved treatment for spinal muscular atrophy. Read the story »
Big bold dreamers 12/10/2018 Dreamers drive discoveries. CSHL honors its many scientists making big impacts in their respective fields. Read the story »
Breakthrough Prize laureates meet at CSHL 12/6/2018 Breakthrough Prize winner Adrian Krainer & C. Frank Bennett reunite for the first time since their award ceremony at CSHL to discuss further project. Read the story »
Adrian Krainer, ganador del Breakthough Prize 10/19/2018 Profesor Adrian Krainer desarrolló un tratamiento para la Atrofia Muscular Espinal. Por su trabajo, recibió el prestigioso el Breakthrough Prize. Watch the video »
The hope of a Breakthough Prize Winner 10/17/2018 Professor Adrian Krainer describes the hope he fulfilled with the development of the first effective therapy for the neurodegenerative disease SMA. Watch the video »
Breakthrough Prize to CSHL professor for SMA research 10/17/2018 Professor Adrian Krainer recently received the 2019 Breakthrough Prize in Life Sciences for the development of a life-saving treatment for SMA. Watch the video »
Breakthrough Prize to CSHL professor for SMA research 10/17/2018 Professor Adrian Krainer has received a Breakthrough Prize in Life Sciences for his work on the first FDA-approved treatment of SMA. Read the story »
CSHL helps ring opening bell at Nasdaq 8/21/2018 CSHL Professor Adrian Krainer and his team join the Spinal Muscular Atrophy (SMA) Foundation in ringing the Nasdaq opening bell Read the story »
SMA and the drug that fights it, explained 12/28/2016 With help from our friends at Youreka Science, CSHL explains SMA and the promising solution that fights it. Watch the video »
FDA approval of life-saving SMA drug is hailed by its researcher-inventor at CSHL 12/24/2016 Nusinersen (Spinraza) will be used to treat young children with a severe and potentially fatal illness called spinal muscular atrophy (SMA). Read the story »
One experiment: A drug for SMA visibly repairs defective cells 12/1/2016 Professor Adrian Krainer develops a treatment for spinal muscular atrophy, the leading genetic cause of infant death. Read the story »
